ClassID:

95260

C07D405/12 - page 6 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#1501
20210115054
2021-04-22

Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists

#1502
20210115031
2021-04-22

Benzofurane and benzothiophene derivatives as PGE2 receptor modulators

#1503
20210115026
2021-04-22

Anthelmintic quinoline-3-carboxamide derivatives

#1504
20210115025
2021-04-22

Heterocyclic compounds as immunomodulators

#1505
20210115024
2021-04-22

Small molecule inducers of autophagy

#1506
20210115016
2021-04-22

Amido compounds as AhR modulators

#1507
20210114992
2021-04-22

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#1508
20210114991
2021-04-22

INHIBITION OF OLIG2 ACTIVITY

#1509
20210114982
2021-04-22

Indole derivatives and their use as protein kinase inhibitors

#1510
20210113559
2021-04-22

Pyrimidine derivatives as PGE2 receptor modulators

#1511
20210113556
2021-04-22

Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders

#1512
20210107914
2021-04-15

OX2R compounds

#1513
20210107910
2021-04-15

Compositions and Methods of Using the Same for Treatment of Neurodegenerative and Mitochondrial Disease

#1514
20210107876
2021-04-15

Histone methyltransferase inhibitors

#1515
20210107869
2021-04-15

Urea derivative or pharmacologically acceptable salt thereof

#1516
20210104674
2021-04-08

Compound and organic light-emitting device including the same

#1517
20210101888
2021-04-08

Splicing modulator antibody-drug conjugates and methods of use

#1518
20210101878
2021-04-08

Cannabinergic compounds and uses thereof

#1519
20210101877
2021-04-08

Anti-infective agents

#1520
20210094937
2021-04-01

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

#1521
20210094923
2021-04-01

Pyrimidine compounds useful as tyrosine kinase inhibitors

#1522
20210094906
2021-04-01

Carboxamides as modulators of sodium channels

#1523
20210093618
2021-04-01

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#1524
20210087181
2021-03-25

Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof

#1525
20210079017
2021-03-18

Neprilysin inhibitors

#1526
20210078988
2021-03-18

MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE

#1527
20210078987
2021-03-18

Compound and pharmaceutical composition comprising same

#1528
20210078958
2021-03-18

QUINAZOLINE DERIVATIVE AND USE THEREOF

#1529
20210078952
2021-03-18

Human plasma kallikrein inhibitors

#1530
20210078951
2021-03-18

Arginine methyltransferase inhibitors and uses thereof

#1531
20210070767
2021-03-11

Apelin receptor (APJ) agonists and uses thereof

#1532
20210070713
2021-03-11

Pesticidal compounds

#1533
20210070708
2021-03-11

Pharmaceutically Active Compounds

#1534
20210070707
2021-03-11

PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING

#1535
20210069203
2021-03-11

DNA-PK inhibitors

#1536
20210069172
2021-03-11

Methods and compositions of inhibiting DCN1-UBC12 interaction

#1537
20210061792
2021-03-04

Process and crystalline forms of Lumacaftor

#1538
20210061762
2021-03-04

P300/CBP hat inhibitors

#1539
20210060205
2021-03-04

AFIBROTIC COMPOUNDS, DEVICES, AND USES THEREOF

#1540
20210060027
2021-03-04

Substituted benzene compounds

#1541
20210059251
2021-03-04

PLANT GROWTH REGULATOR COMPOUNDS

#1542
20210053981
2021-02-25

ANTIVIRAL COMPOUNDS

#1543
20210053975
2021-02-25

Inhibitors of protein arginine deiminases

#1544
20210053956
2021-02-25

1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors

#1545
20210053949
2021-02-25

Process and crystalline forms of lumacaftor

#1546
20210053948
2021-02-25

Combination therapy for treating cancer

#1547
20210053924
2021-02-25

Heterocyclic compounds as pesticides

#1548
20210052586
2021-02-25

Compounds and methods for treating oxalate-related diseases

#1549
20210052550
2021-02-25

COMPOSITION COMPRISING TETRACYCLIC COMPOUND

#1550
20210052514
2021-02-25

Immunomodulator compounds

#1551
20210047305
2021-02-18

Inhibitors of RAS-effector protein interactions

#1552
20210047304
2021-02-18

Bromodomain Inhibitors

#1553
20210047301
2021-02-18

2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

#1554
20210047284
2021-02-18

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#1555
20210047276
2021-02-18

Human plasma kallikrein inhibitors

#1556
20210047275
2021-02-18

Human plasma kallikrein inhibitors

#1557
20210047274
2021-02-18

Herbicidal compounds

#1558
20210047271
2021-02-18

Pyridone amides as modulators of sodium channels

#1559
20210047270
2021-02-18

Benzamide compound and preparation method, use, and pharmaceutical composition thereof

#1560
20210047269
2021-02-18

TRIGONELLINE BASED COMPOUNDS

#1561
20210041465
2021-02-11

Fluorogenic pH sensitive dyes and their method of use

#1562
20210040240
2021-02-11

Photolabile barbiturate compounds

#1563
20210040148
2021-02-11

Therapeutics for the treatment of glaucoma

#1564
20210040108
2021-02-11

Inhibitors of RAD52 Recombination Protein and Methods Using Same

#1565
20210040099
2021-02-11

Compounds for the treatment of kinase-dependent disorders

#1566
20210040076
2021-02-11

Compounds for the treatment of kinase-dependent disorders

#1567
20210040072
2021-02-11

NTCP inhibitors

#1568
20210040041
2021-02-11

QUINOLINE DERIVATIVES AND PREPARATION METHODS AND USES THEREOF

#1569
20210038590
2021-02-11

Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application

#1570
20210032286
2021-02-04

PSMA Imaging Agents

#1571
20210032265
2021-02-04

COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY

#1572
20210032239
2021-02-04

Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof

#1573
20210032233
2021-02-04

Inhibitors of Beta-Hydroxylase for Treatment of Cancer

#1574
20210032231
2021-02-04

Compounds and their use as PDE4 activators

#1575
20210032212
2021-02-04

Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone

#1576
20210030001
2021-02-04

Insecticidal compositions and methods

#1577
20210024574
2021-01-28

PSMA imaging agents

#1578
20210024506
2021-01-28

Polymorphic forms of Afatinib free base and Afatinib dimaleate

#1579
20210024505
2021-01-28

Modulators of ATP-binding cassette transporters

#1580
20210024491
2021-01-28

Bicyclic carboxamides and methods of use thereof

#1581
20210024487
2021-01-28

Cyclopropylamines as LSD1 inhibitors

#1582
20210024484
2021-01-28

Compounds for treating mitochondrial disease

#1583
20210024464
2021-01-28

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

#1584
20210023084
2021-01-28

Compounds

#1585
20210023082
2021-01-28

Pyrimidine derivatives for the treatment of viral infections

#1586
20210021303
2021-01-21

Apparatus for coupling to existing power lines

#1587
20210017164
2021-01-21

Heterocyclic compounds as immunomodulators

#1588
20210017163
2021-01-21

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

#1589
20210017154
2021-01-21

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof

#1590
20210017153
2021-01-21

AHR inhibitors and uses thereof

#1591
20210017136
2021-01-21

Heterocyclic compounds as pesticides

#1592
20210017120
2021-01-21

Nitrobenzyl derivatives of anti-cancer agents

#1593
20210015825
2021-01-21

Theramutein modulators

#1594
20210013420
2021-01-14

Compound for organic electric element, organic electric element comprising the same, and electronic device thereof

#1595
20210009576
2021-01-14

Compounds

#1596
20210009570
2021-01-14

Micronized 1,4-di(benzoxazol-2′-yl)benzene

#1597
20210009533
2021-01-14

Methods for 1,4-diazo N-heterocycle synthesis

#1598
20210009531
2021-01-14

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#1599
20210009524
2021-01-14

MCT4 inhibitors for treating disease

#1600
20210009520
2021-01-14

Histone demethylase inhibitors

#1601
20210008077
2021-01-14

Theramutein modulators

#1602
20210002274
2021-01-07

Sulfonyl acetamides as NLRP3 inhibitors

#1603
20210002264
2021-01-07

Pyrazole-containing macrophage migration inhibitory factor inhibitors

#1604
20210002261
2021-01-07

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

#1605
20210002253
2021-01-07

Aryl cyclopropyl-amino-isoquinolinyl amide compounds

#1606
20210002252
2021-01-07

Methods and compounds for restoring mutant p53 function

#1607
20210002234
2021-01-07

Triazabutadienes as cleavable cross-linkers

#1608
20210002233
2021-01-07

PKM2 MODULATORS AND METHODS FOR THEIR USE

#1609
20210002230
2021-01-07

Oxoacridinyl acetic acid derivatives and methods of use

#1610
20210002221
2021-01-07

Catalysts and methods for enantioselective conjugate addition of amines to unsaturated electrophiles

#1611
20210000818
2021-01-07

Methods for treating depressive symptoms

#1612
20200407345
2020-12-31

Compositions and methods for treating infections

#1613
20200407328
2020-12-31

BRD4-kinase inhibitors as cancer therapeutics

#1614
20200407327
2020-12-31

Tead inhibitors and uses thereof

#1615
20200407319
2020-12-31

ALKYNYL PYRIDINE PROLYL HYDROXYLASE INHIBITOR, AND PREPARATION METHOD AND MEDICAL USE THEREOF

#1616
20200399280
2020-12-24

3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1617
20200399230
2020-12-24

Triazine derivatives for treating diseases relating to neurotrophins

#1618
20200399226
2020-12-24

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

#1619
20200397755
2020-12-24

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO

#1620
20200397000
2020-12-24

Unusually potent ABA receptor pan-antagonists

#1621
20200392157
2020-12-17

Calpain modulators and therapeutic uses thereof

#1622
20200392140
2020-12-17

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

#1623
20200392120
2020-12-17

Preparation containing benzimidazole derivative

#1624
20200392100
2020-12-17

Processes for preparing antiviral compounds

#1625
20200392098
2020-12-17

Process for producing a hydrate of a hydrochloride salt of 2,2′-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid

#1626
20200392081
2020-12-17

NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF

#1627
20200390776
2020-12-17

Isofuranone compounds useful as HPK1 inhibitors

#1628
20200390750
2020-12-17

Modifiers of CFTR-directed therapy

#1629
20200385375
2020-12-10

Acid addition salts of piperazine derivatives

#1630
20200385367
2020-12-10

Calcium channel inhibitors

#1631
20200385354
2020-12-10

Quinoline sulfonamide compounds and their use as antibacterial agents

#1632
20200385345
2020-12-10

Substituted pyrrolidine compound and use thereof

#1633
20200384114
2020-12-10

Cholecystokinin B receptor targeting for imaging and therapy

#1634
20200383988
2020-12-10

Compounds

#1635
20200383979
2020-12-10

Triaryl compounds for treatment of PD-L1 diseases

#1636
20200377549
2020-12-03

PSMA imaging agents

#1637
20200377511
2020-12-03

Bicyclic-fused heteroaryl or aryl compounds

#1638
20200377510
2020-12-03

DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF

#1639
20200377487
2020-12-03

SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS

#1640
20200377486
2020-12-03

Quinoline derivatives for treating infections with helminths

#1641
20200377484
2020-12-03

Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

#1642
20200377483
2020-12-03

NEW ANTI-MALARIAL AGENT

#1643
20200377472
2020-12-03

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#1644
20200377465
2020-12-03

Substituted piperazines as selective HDAC1,2 inhibitors

#1645
20200377460
2020-12-03

Anti-inflammatory compound, and preparation and use thereof

#1646
20200376131
2020-12-03

Pegylated carfilzomib compounds

#1647
20200375969
2020-12-03

Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6

#1648
20200369663
2020-11-26

Compounds and compositions for the treatment of cystic fibrosis

#1649
20200369626
2020-11-26

COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF

#1650
20200369621
2020-11-26

Substituted imidazole carboxylate derivatives and the use thereof

#1651
20200361925
2020-11-19

INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER

#1652
20200361918
2020-11-19

Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof

#1653
20200360521
2020-11-19

TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS

#1654
20200360379
2020-11-19

Hydantoin derivatives useful as Kv3 inhibitors

#1655
20200360348
2020-11-19

Compounds, compositions, and methods of increasing CFTR activity

#1656
20200358477
2020-11-12

Redundant power line control systems

#1657
20200354381
2020-11-12

Biocompatible modular tetrazine platform

#1658
20200354351
2020-11-12

Compositions and methods for viral sensitization

#1659
20200354349
2020-11-12

Benzofuran derivative, preparation method thereof and use thereof in medicine

#1660
20200347078
2020-11-05

Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors

#1661
20200347043
2020-11-05

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#1662
20200347042
2020-11-05

Chromene derivatives as inhibitors of TCR-Nck interaction

#1663
20200347038
2020-11-05

QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE

#1664
20200347025
2020-11-05

Compounds and compositions for inhibition of FASN

#1665
20200345735
2020-11-05

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#1666
20200343450
2020-10-29

ORGANIC LIGHT-EMITTING DIODE

#1667
20200339591
2020-10-29

COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA

#1668
20200339549
2020-10-29

CXCR2 antagonist

#1669
20200339542
2020-10-29

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#1670
20200339535
2020-10-29

Inhibitors of dihydroceramide desaturase for treating disease

#1671
20200339534
2020-10-29

BENZAMIDE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASE CONTAINING SAME AS ACTIVE INGREDIENT

#1672
20200339533
2020-10-29

Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof

#1673
20200338102
2020-10-29

Catecholamine prodrugs for use in the treatment of Parkinson's disease

#1674
20200338070
2020-10-29

Compositions and methods for treating EZH2-mediated cancer

#1675
20200331872
2020-10-22

Methionine metabolic pathway inhibitors

#1676
20200331847
2020-10-22

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#1677
20200325122
2020-10-15

Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

#1678
20200323866
2020-10-15

EZH2 inhibitors for treating lymphoma

#1679
20200323850
2020-10-15

Pyrimidine derivative kinase inhibitors

#1680
20200323821
2020-10-15

Pyrrole compounds

#1681
20200321526
2020-10-08

Aromatic amine derivative, and organic electroluminescent element using same

#1682
20200317714
2020-10-08

Cyclic peroxides as prodrugs for selective delivery of agents

#1683
20200317651
2020-10-08

Modulators of methyl modifying enzymes, compositions and uses thereof

#1684
20200317649
2020-10-08

Azole analogues and methods of use thereof

#1685
20200317648
2020-10-08

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#1686
20200317647
2020-10-08

Compounds and their use as selective inhibitors of caspase-2

#1687
20200317644
2020-10-08

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

#1688
20200317637
2020-10-08

Sulfonamide carboxamide compounds

#1689
20200317630
2020-10-08

Anticancer agent

#1690
20200317629
2020-10-08

Benzo-fused heterocyclic derivatives useful as agonists of GPR120

#1691
20200317624
2020-10-08

BICYCLIC QUINAZOLINONE DERIVATIVES

#1692
20200317620
2020-10-08

Selective inhibition of gluconeogenic activity

#1693
20200317610
2020-10-08

Hydrazinyl-pyrrolo compounds and methods for producing a conjugate

#1694
20200316079
2020-10-08

ErbB/BTK inhibitors

#1695
20200315174
2020-10-08

Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents

#1696
20200313090
2020-10-01

Aromatic amine derivative, and organic electroluminescent element using same

#1697
20200308181
2020-10-01

Diamine derivatives as inhibitors of leukotriene A4 hydrolase

#1698
20200308155
2020-10-01

Substituted ureas and methods of making and using same

#1699
20200308153
2020-10-01

Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives

#1700
20200306259
2020-10-01

Substituted quinazolines for inhibiting kinase activity

#1701
20200303654
2020-09-24

Materials for electronic devices

#1702
20200299307
2020-09-24

Androgen receptor modulating compounds

#1703
20200299285
2020-09-24

Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

#1704
20200299261
2020-09-24

WNT signaling pathway inhibitors for treatments of disease

#1705
20200299237
2020-09-24

Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists

#1706
20200299236
2020-09-24

COLORED PHOTOSENSITIVE RESIN COMPOSITION AND LIGHT SHIELDING SPACER PREPARED THEREFROM

#1707
20200299234
2020-09-24

Compositions for treating neurodegenerative diseases

#1708
20200297726
2020-09-24

PYRIMIDINEDIONE COMPOUNDS

#1709
20200297710
2020-09-24

Chemical compounds

#1710
20200297700
2020-09-24

BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF

#1711
20200295262
2020-09-17

CONTROLLING ZONES OF ELECTRONIC DEVICES ASSOCIATED WITH POWER LINES

#1712
20200291011
2020-09-17

Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

#1713
20200291009
2020-09-17

2,3-dihydrobenzohurans as bromodomain inhibitors

#1714
20200291002
2020-09-17

Benzofuran derivatives for the treatment of hepatitis C

#1715
20200291000
2020-09-17

Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

#1716
20200290996
2020-09-17

Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

#1717
20200290977
2020-09-17

Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

#1718
20200290973
2020-09-17

Farnesoid X receptor agonists and uses thereof

#1719
20200290969
2020-09-17

Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor

#1720
20200289502
2020-09-17

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

#1721
20200289464
2020-09-17

Benzofuran derivatives and their use as bromodomain inhibitors

#1722
20200283441
2020-09-10

Compounds for improving mRNA splicing

#1723
20200283426
2020-09-10

ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE

#1724
20200283423
2020-09-10

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

#1725
20200283422
2020-09-10

Neprilysin inhibitors

#1726
20200283395
2020-09-10

2-phenylpyrimidine-4-carboxamides as AHR inhibitors

#1727
20200283391
2020-09-10

Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

#1728
20200283386
2020-09-10

Materials for electronic devices

#1729
20200283385
2020-09-10

Salts and prodrugs of 1-methyl-d-tryptophan

#1730
20200283383
2020-09-10

MEK inhibitors and methods of their use

#1731
20200281899
2020-09-10

Small molecule regulators of mitochondrial fusion and methods of use thereof

#1732
20200276337
2020-09-03

Radiolabeled Darapladib and analogs thereof and their use as imaging compounds

#1733
20200276180
2020-09-03

Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor

#1734
20200275661
2020-09-03

QUINOLINE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE

#1735
20200275657
2020-09-03

Microbiocidal quinoline (thio)carboxamide derivatives

#1736
20200275655
2020-09-03

Pyridinium salt and pest control agent

#1737
20200270252
2020-08-27

Fused indazole pyridone compounds as antivirals

#1738
20200270239
2020-08-27

Compounds, salts thereof and methods for treatment of diseases

#1739
20200270238
2020-08-27

Pyrimidinyloxy benzene derivatives as herbicides

#1740
20200270232
2020-08-27

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

#1741
20200270211
2020-08-27

Compounds, compositions and methods of use

#1742
20200270205
2020-08-27

Cannabinoid receptor CB2 ligand 4-(aminomethyl)-N, N-dialkylanilines

#1743
20200268709
2020-08-27

Small molecules against cancer

#1744
20200262850
2020-08-20

SUBSTITUTED ASYMMETRIC UREAS AS MODULATORS OF GHRELIN RECEPTOR ACTIVITY

#1745
20200262836
2020-08-20

Inhibitors of hepatitis C virus replication

#1746
20200262823
2020-08-20

METHODS OF TREATING CANCER

#1747
20200262822
2020-08-20

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases

#1748
20200262796
2020-08-20

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

#1749
20200255446
2020-08-13

Compositions and methods for treating cancer

#1750
20200255413
2020-08-13

Antibacterial compounds

#1751
20200255412
2020-08-13

Imidazolecarboxamides and Their Use as FAAH Inhibitors

#1752
20200255409
2020-08-13

Potassium channel inhibitors

#1753
20200255407
2020-08-13

Quinazolines as potassium ion channel inhibitors

#1754
20200255400
2020-08-13

Microbiocidal picolinamide derivatives

#1755
20200255385
2020-08-13

Hydantoin containing deoxyuridine triphosphatase inhibitors

#1756
20200253974
2020-08-13

Quinazoline compounds as modulators of Ras signaling

#1757
20200247814
2020-08-06

Hetero-halo inhibitors of histone deacetylase

#1758
20200247795
2020-08-06

Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same

#1759
20200247789
2020-08-06

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#1760
20200247788
2020-08-06

Quinazolinones as PARP14 inhibitors

#1761
20200247774
2020-08-06

PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#1762
20200247762
2020-08-06

K-Ras modulators

#1763
20200247760
2020-08-06

Compounds, compositions and methods for treatment of myopia

#1764
20200247755
2020-08-06

ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#1765
20200247754
2020-08-06

Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use

#1766
20200246286
2020-08-06

Imaging composition and uses thereof

#1767
20200239490
2020-07-30

Pyridine derivatives

#1768
20200239458
2020-07-30

Inhibitors of protein kinases

#1769
20200239455
2020-07-30

Dantrolene prodrugs and methods of their use

#1770
20200239454
2020-07-30

Sulfonyl substituted bicyclic compound which acts as ROR inhibitor

#1771
20200239417
2020-07-30

Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer

#1772
20200239415
2020-07-30

EBNA1 inhibitors and methods using same

#1773
20200237763
2020-07-30

3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulators

#1774
20200237757
2020-07-30

3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides

#1775
20200237755
2020-07-30

Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders

#1776
20200230123
2020-07-23

Biaryloxy derivatives as TTX-S blockers

#1777
20200225217
2020-07-16

Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

#1778
20200223845
2020-07-16

Viral replication inhibitors

#1779
20200223833
2020-07-16

Phenyl propionic acid derivatives and uses thereof

#1780
20200223832
2020-07-16

Processes for the preparation of Tezacaftor and intermediates thereof

#1781
20200223830
2020-07-16

Bisamide sarcomere activating compounds and uses thereof

#1782
20200223829
2020-07-16

Bisamide sarcomere activating compounds and uses thereof

#1783
20200223818
2020-07-16

Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

#1784
20200223817
2020-07-16

Method of treating or preventing Ras-mediated diseases

#1785
20200223816
2020-07-16

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#1786
20200223815
2020-07-16

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

#1787
20200223813
2020-07-16

Prodrugs of urolithins and uses thereof

#1788
20200223810
2020-07-16

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#1789
20200223806
2020-07-16

P2X4 receptor antagonist

#1790
20200222380
2020-07-16

Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same

#1791
20200216490
2020-07-09

PPAR agonists and methods of use thereof

#1792
20200216469
2020-07-09

Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies

#1793
20200216434
2020-07-09

BENZOFURAN UREAS OR CARBAMATES AND HETEROAROMATIC ANALOGUES THEREOF FOR USE IN THERAPY

#1794
20200216426
2020-07-09

Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria

#1795
20200216397
2020-07-09

5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

#1796
20200207809
2020-07-02

Tripeptide epoxy ketone protease inhibitors

#1797
20200207783
2020-07-02

Glutarimides for medical treatment

#1798
20200207769
2020-07-02

DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE

#1799
20200207764
2020-07-02

Dihydrobenzimidazolones for medical treatment

#1800
20200207749
2020-07-02

Compounds for use as therapeutically active substances in the treatment of retinal diseases